Literature DB >> 33775913

Membrane-associated mucins of the human ocular surface in health and disease.

Rafael Martinez-Carrasco1, Pablo Argüeso2, M Elizabeth Fini3.   

Abstract

Mucins are a family of high molecular weight, heavily-glycosylated proteins produced by wet epithelial tissues, including the ocular surface epithelia. Densely-packed O-linked glycan chains added post-translationally confer the biophysical properties of hydration, lubrication, anti-adhesion and repulsion. Membrane-associated mucins (MAMs) are the distinguishing components of the mucosal glycocalyx. At the ocular surface, MAMs maintain wetness, lubricate the blink, stabilize the tear film, and create a physical barrier to the outside world. In addition, it is increasingly appreciated that MAMs function as cell surface receptors that transduce information from the outside to the inside of the cell. Recently, our team published a comprehensive review/perspectives article for molecular scientists on ocular surface MAMs, including previously unpublished data and analyses on two new genes MUC21 and MUC22, as well as new MAM functions and biological roles, comparing human and mouse (PMID: 31493487). The current article is a refocus for the audience of The Ocular Surface. First, we update the gene and protein information in a more concise form, and include a new section on glycosylation. Next, we discuss biological roles, with some new sections and further updating from our previous review. Finally, we provide a new chapter on MAM involvement in ocular surface disease. We end this with discussion of an emerging mechanism responsible for damage to the epithelia and their mucosal glycocalyces: the unfolded protein response (UPR). The UPR offers a novel target for therapeutic intervention.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Barrier function; Glycocalyx; Membrane-associated mucin; Mucosal epithelia; O-linked glycosylation; Ocular surface; Oxidative stress; Signal transduction; Unfolded protein response

Mesh:

Substances:

Year:  2021        PMID: 33775913      PMCID: PMC8328898          DOI: 10.1016/j.jtos.2021.03.003

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   6.268


  240 in total

Review 1.  Cellular origin of mucins of the ocular surface tear film.

Authors:  I K Gipson; T Inatomi
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

2.  Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen.

Authors:  Wei Guang; Hua Ding; Steven J Czinn; K Chul Kim; Thomas G Blanchard; Erik P Lillehoj
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

3.  Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury.

Authors:  Sang-Bing Ong; Sapna Subrayan; Shiang Y Lim; Derek M Yellon; Sean M Davidson; Derek J Hausenloy
Journal:  Circulation       Date:  2010-04-26       Impact factor: 29.690

4.  Epithelial membrane antigen (EMA) or MUC1 expression in monocytes and monoblasts.

Authors:  Chooi-Fun Leong; Osman Raudhawati; Soon-Keng Cheong; Kulaveerasingam Sivagengei; Hussin Noor Hamidah
Journal:  Pathology       Date:  2003-10       Impact factor: 5.306

5.  Alteration of mucin in human conjunctival epithelia in dry eye.

Authors:  Y Danjo; H Watanabe; A S Tisdale; M George; T Tsumura; M B Abelson; I K Gipson
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-12       Impact factor: 4.799

6.  Studies on the isolation and composition of human ocular mucin.

Authors:  C C Chao; S M Butala; A Herp
Journal:  Exp Eye Res       Date:  1988-08       Impact factor: 3.467

Review 7.  TLR Activation and Allergic Disease: Early Life Microbiome and Treatment.

Authors:  Kathryn R Michels; Nicholas W Lukacs; Wendy Fonseca
Journal:  Curr Allergy Asthma Rep       Date:  2018-09-26       Impact factor: 4.806

Review 8.  The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.

Authors:  Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Ophthalmology       Date:  2017-11       Impact factor: 12.079

9.  MUC19 expression in human ocular surface and lacrimal gland and its alteration in Sjögren syndrome patients.

Authors:  D F Yu; Y Chen; J M Han; H Zhang; X P Chen; W J Zou; L Y Liang; C C Xu; Z G Liu
Journal:  Exp Eye Res       Date:  2007-11-28       Impact factor: 3.467

10.  Comparison of the transmembrane mucins MUC1 and MUC16 in epithelial barrier function.

Authors:  Ilene K Gipson; Sandra Spurr-Michaud; Ann Tisdale; Balaraj B Menon
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

View more
  6 in total

1.  Ocular microbiota promotes pathological angiogenesis and inflammation in sterile injury-driven corneal neovascularization.

Authors:  Hyun Ju Lee; Chang Ho Yoon; Hyeon Ji Kim; Jung Hwa Ko; Jin Suk Ryu; Dong Hyun Jo; Jeong Hun Kim; Donghyun Kim; Joo Youn Oh
Journal:  Mucosal Immunol       Date:  2022-08-19       Impact factor: 8.701

2.  Secreted Ly-6/uPAR-related protein-1 (SLURP1) is a pro-differentiation factor that stalls G1-S transition during corneal epithelial cell cycle progression.

Authors:  Sudha Swamynathan; Gregory Campbell; Anil Tiwari; Shivalingappa K Swamynathan
Journal:  Ocul Surf       Date:  2021-12-16       Impact factor: 6.268

3.  Transcriptome Analysis of Pterygium and Pinguecula Reveals Evidence of Genomic Instability Associated with Chronic Inflammation.

Authors:  María Fernanda Suarez; José Echenique; Juan Manuel López; Esteban Medina; Mariano Irós; Horacio M Serra; M Elizabeth Fini
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

Review 4.  Advances in MUC1-Mediated Breast Cancer Immunotherapy.

Authors:  Zhifeng Li; Dazhuang Yang; Ting Guo; Mei Lin
Journal:  Biomolecules       Date:  2022-07-06

Review 5.  Epithelial barrier dysfunction in ocular allergy.

Authors:  Neera Singh; Yolanda Diebold; Srikant K Sahu; Andrea Leonardi
Journal:  Allergy       Date:  2021-11-28       Impact factor: 14.710

Review 6.  MUC1: Structure, Function, and Clinic Application in Epithelial Cancers.

Authors:  Wenqing Chen; Zhu Zhang; Shiqing Zhang; Peili Zhu; Joshua Ka-Shun Ko; Ken Kin-Lam Yung
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.